

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.86822264 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.68233498 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.45676638 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.30837257 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.30775761 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.19286212 |
| 7 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.16300520 |
| 8 | neuronal action potential propagation (GO:0019227) | 5.07092871 |
| 9 | glutamate secretion (GO:0014047) | 5.06004240 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.05529063 |
| 11 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.96718264 |
| 12 | neuron cell-cell adhesion (GO:0007158) | 4.94831878 |
| 13 | protein localization to synapse (GO:0035418) | 4.94449792 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.91046485 |
| 15 | glutamate receptor signaling pathway (GO:0007215) | 4.66906331 |
| 16 | synaptic transmission, glutamatergic (GO:0035249) | 4.66118828 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.60620940 |
| 18 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.56699281 |
| 19 | neuron-neuron synaptic transmission (GO:0007270) | 4.56033725 |
| 20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.50471060 |
| 21 | synaptic vesicle maturation (GO:0016188) | 4.46441653 |
| 22 | gamma-aminobutyric acid transport (GO:0015812) | 4.44022433 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.34889290 |
| 24 | protein heterotrimerization (GO:0070208) | 4.33538125 |
| 25 | exploration behavior (GO:0035640) | 4.23326537 |
| 26 | positive regulation of synapse maturation (GO:0090129) | 4.23308304 |
| 27 | regulation of synaptic vesicle transport (GO:1902803) | 4.12393493 |
| 28 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.12039592 |
| 29 | endocardial cushion development (GO:0003197) | 4.07352564 |
| 30 | presynaptic membrane assembly (GO:0097105) | 4.05108448 |
| 31 | cerebellar granule cell differentiation (GO:0021707) | 4.01119619 |
| 32 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.98920445 |
| 33 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.95429561 |
| 34 | positive regulation of membrane potential (GO:0045838) | 3.91063961 |
| 35 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.90911896 |
| 36 | long-term memory (GO:0007616) | 3.89969337 |
| 37 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.89861279 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.79859694 |
| 39 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.79492404 |
| 40 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.76438584 |
| 41 | long-term synaptic potentiation (GO:0060291) | 3.74452694 |
| 42 | presynaptic membrane organization (GO:0097090) | 3.73686057 |
| 43 | neuron recognition (GO:0008038) | 3.72196026 |
| 44 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.71778224 |
| 45 | layer formation in cerebral cortex (GO:0021819) | 3.62920775 |
| 46 | kidney mesenchyme development (GO:0072074) | 3.62561208 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.61414861 |
| 48 | postsynaptic membrane organization (GO:0001941) | 3.57285199 |
| 49 | neurotransmitter transport (GO:0006836) | 3.52492223 |
| 50 | startle response (GO:0001964) | 3.50973904 |
| 51 | regulation of synapse structural plasticity (GO:0051823) | 3.50180136 |
| 52 | axonal fasciculation (GO:0007413) | 3.47332945 |
| 53 | dendritic spine morphogenesis (GO:0060997) | 3.46494737 |
| 54 | chondrocyte proliferation (GO:0035988) | 3.46276163 |
| 55 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.45489246 |
| 56 | regulation of synapse maturation (GO:0090128) | 3.45451902 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.45094348 |
| 58 | regulation of synaptic plasticity (GO:0048167) | 3.41848537 |
| 59 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.34038787 |
| 60 | cellular response to vitamin (GO:0071295) | 3.33091953 |
| 61 | type B pancreatic cell proliferation (GO:0044342) | 3.30891731 |
| 62 | regulation of neurotransmitter secretion (GO:0046928) | 3.30852574 |
| 63 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.30683629 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 3.29966746 |
| 65 | response to histamine (GO:0034776) | 3.29587814 |
| 66 | mesodermal cell differentiation (GO:0048333) | 3.29046711 |
| 67 | cellular potassium ion homeostasis (GO:0030007) | 3.28868250 |
| 68 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.27014837 |
| 69 | membrane depolarization (GO:0051899) | 3.24190317 |
| 70 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.22969026 |
| 71 | collagen fibril organization (GO:0030199) | 3.19198991 |
| 72 | extracellular matrix assembly (GO:0085029) | 3.18742336 |
| 73 | positive regulation of synapse assembly (GO:0051965) | 3.18408889 |
| 74 | synaptic vesicle endocytosis (GO:0048488) | 3.15797593 |
| 75 | synapse assembly (GO:0007416) | 3.15201441 |
| 76 | transmission of nerve impulse (GO:0019226) | 3.13856972 |
| 77 | membrane hyperpolarization (GO:0060081) | 3.13200107 |
| 78 | hypotonic response (GO:0006971) | 3.12009400 |
| 79 | activation of protein kinase A activity (GO:0034199) | 3.10330718 |
| 80 | proline transport (GO:0015824) | 3.10272130 |
| 81 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.10212625 |
| 82 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.09701669 |
| 83 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.08887038 |
| 84 | smooth muscle tissue development (GO:0048745) | 3.06266161 |
| 85 | positive regulation of synaptic transmission (GO:0050806) | 3.05656197 |
| 86 | dermatan sulfate biosynthetic process (GO:0030208) | 3.04809187 |
| 87 | positive regulation of fibroblast migration (GO:0010763) | 3.04646407 |
| 88 | urinary tract smooth muscle contraction (GO:0014848) | 3.03789723 |
| 89 | regulation of neurotransmitter transport (GO:0051588) | 3.02796757 |
| 90 | membrane depolarization during action potential (GO:0086010) | 3.02615090 |
| 91 | synaptic transmission (GO:0007268) | 3.02208801 |
| 92 | regulation of glutamate secretion (GO:0014048) | 3.01016001 |
| 93 | positive regulation of neurotransmitter transport (GO:0051590) | 3.00357209 |
| 94 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.98485296 |
| 95 | learning (GO:0007612) | 2.98465883 |
| 96 | regulation of vesicle fusion (GO:0031338) | 2.98354572 |
| 97 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.98107901 |
| 98 | bone trabecula formation (GO:0060346) | 2.96702634 |
| 99 | regulation of synaptic transmission (GO:0050804) | 2.96554894 |
| 100 | regulation of dendritic spine development (GO:0060998) | 2.96217096 |
| 101 | long term synaptic depression (GO:0060292) | 2.93037466 |
| 102 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.92505919 |
| 103 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.91857876 |
| 104 | behavioral response to cocaine (GO:0048148) | 2.91615577 |
| 105 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.89528002 |
| 106 | cell differentiation in hindbrain (GO:0021533) | 2.89302048 |
| 107 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.88860139 |
| 108 | synapse organization (GO:0050808) | 2.88349118 |
| 109 | cell adhesion mediated by integrin (GO:0033627) | 2.85841080 |
| 110 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.84609236 |
| 111 | cell migration involved in heart development (GO:0060973) | 2.84015139 |
| 112 | response to gravity (GO:0009629) | 2.83677102 |
| 113 | neuromuscular process controlling posture (GO:0050884) | 2.82835619 |
| 114 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.81974220 |
| 115 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.80520895 |
| 116 | neuromuscular process controlling balance (GO:0050885) | 2.80356059 |
| 117 | dermatan sulfate metabolic process (GO:0030205) | 2.80331685 |
| 118 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.79149734 |
| 119 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.78571417 |
| 120 | intraspecies interaction between organisms (GO:0051703) | 2.77959250 |
| 121 | social behavior (GO:0035176) | 2.77959250 |
| 122 | positive regulation of dendritic spine development (GO:0060999) | 2.76027002 |
| 123 | neuromuscular process (GO:0050905) | 2.75713558 |
| 124 | negative regulation of axon guidance (GO:1902668) | 2.73469150 |
| 125 | dendrite morphogenesis (GO:0048813) | 2.73421024 |
| 126 | innervation (GO:0060384) | 2.72916092 |
| 127 | behavioral defense response (GO:0002209) | 2.71878859 |
| 128 | behavioral fear response (GO:0001662) | 2.71878859 |
| 129 | relaxation of smooth muscle (GO:0044557) | 2.71553566 |
| 130 | pericardium development (GO:0060039) | 2.71245162 |
| 131 | metanephric mesenchyme development (GO:0072075) | 2.70886945 |
| 132 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.70806624 |
| 133 | endodermal cell differentiation (GO:0035987) | 2.69859127 |
| 134 | protein localization to cell surface (GO:0034394) | 2.69246150 |
| 135 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.67914879 |
| 136 | cellular response to vitamin D (GO:0071305) | 2.65555416 |
| 137 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.65270966 |
| 138 | negative regulation of fatty acid transport (GO:2000192) | 2.62012138 |
| 139 | adhesion of symbiont to host cell (GO:0044650) | 2.61052465 |
| 140 | virion attachment to host cell (GO:0019062) | 2.61052465 |
| 141 | negative regulation of osteoblast proliferation (GO:0033689) | 2.60664302 |
| 142 | inner ear receptor cell development (GO:0060119) | 2.60597915 |
| 143 | skin morphogenesis (GO:0043589) | 2.59090219 |
| 144 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.54643863 |
| 145 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.47740858 |
| 146 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.47565383 |
| 147 | regulation of axon guidance (GO:1902667) | 2.47053537 |
| 148 | positive regulation of axon extension (GO:0045773) | 2.45500257 |
| 149 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.38899572 |
| 150 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.38823766 |
| 151 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.32361038 |
| 152 | tonic smooth muscle contraction (GO:0014820) | 2.31946097 |
| 153 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.30094822 |
| 154 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.29654639 |
| 155 | retinal cone cell development (GO:0046549) | 2.29141156 |
| 156 | negative regulation of protein localization to cell surface (GO:2000009) | 2.28098290 |
| 157 | sleep (GO:0030431) | 2.27078157 |
| 158 | substrate-dependent cell migration (GO:0006929) | 2.25973336 |
| 159 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 2.25337916 |
| 160 | anterior/posterior axis specification, embryo (GO:0008595) | 2.25101269 |
| 161 | SMAD protein complex assembly (GO:0007183) | 2.23662648 |
| 162 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.22971389 |
| 163 | cGMP-mediated signaling (GO:0019934) | 2.19979012 |
| 164 | negative regulation of hormone metabolic process (GO:0032351) | 2.19352732 |
| 165 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.16843508 |
| 166 | cellular response to epinephrine stimulus (GO:0071872) | 2.16637253 |
| 167 | serotonin metabolic process (GO:0042428) | 2.15873966 |
| 168 | positive regulation of male gonad development (GO:2000020) | 2.15532860 |
| 169 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.15314781 |
| 170 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.14967920 |
| 171 | positive regulation of cGMP metabolic process (GO:0030825) | 2.13105691 |
| 172 | regulation of cGMP metabolic process (GO:0030823) | 2.11559516 |
| 173 | response to magnesium ion (GO:0032026) | 2.09974586 |
| 174 | positive regulation of catecholamine secretion (GO:0033605) | 2.09454287 |
| 175 | regulation of smooth muscle cell migration (GO:0014910) | 2.08792598 |
| 176 | axon extension (GO:0048675) | 2.08112417 |
| 177 | cell-substrate junction assembly (GO:0007044) | 2.06338586 |
| 178 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.05735511 |
| 179 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.03977593 |
| 180 | endocrine hormone secretion (GO:0060986) | 2.03859248 |
| 181 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.03588381 |
| 182 | lymphangiogenesis (GO:0001946) | 2.03482877 |
| 183 | relaxation of muscle (GO:0090075) | 2.02489366 |
| 184 | adhesion of symbiont to host (GO:0044406) | 2.01719774 |
| 185 | protein targeting to plasma membrane (GO:0072661) | 2.01421272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.72716333 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.11796909 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09212611 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06378050 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05780014 |
| 6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.85016516 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.66300939 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.66300939 |
| 9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.56357668 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.56282817 |
| 11 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54966601 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.52301719 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.45563663 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43359330 |
| 15 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.43225764 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38515289 |
| 17 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35921652 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35220591 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.22484593 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.18575998 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.16213387 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10601016 |
| 23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.07616754 |
| 24 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.02461365 |
| 25 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01398995 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.00400103 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.97477689 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.97305421 |
| 29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.95417686 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.89012796 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.87939824 |
| 32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.81788340 |
| 33 | CJUN_26792858_Chip-Seq_BT549_Human | 1.80172182 |
| 34 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.77845737 |
| 35 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.77151432 |
| 36 | * ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.72973159 |
| 37 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.72824740 |
| 38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.71633538 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71606002 |
| 40 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.69510364 |
| 41 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.69510364 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68593240 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.58757037 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57420831 |
| 45 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57247946 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51633841 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.50233876 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49943781 |
| 49 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.49886491 |
| 50 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.49207481 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48506950 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.44461204 |
| 53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44358081 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42556802 |
| 55 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39997950 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39102456 |
| 57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.38924358 |
| 58 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38283605 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36472084 |
| 60 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35223814 |
| 61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34848594 |
| 62 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.34615080 |
| 63 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33154867 |
| 64 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32717794 |
| 65 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31637632 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27643898 |
| 67 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.26734447 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26612388 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26488191 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20842015 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20528789 |
| 72 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.19926012 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19812355 |
| 74 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19324397 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18035867 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17686504 |
| 77 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17588627 |
| 78 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17359279 |
| 79 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16944386 |
| 80 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.16732927 |
| 81 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16585175 |
| 82 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15606564 |
| 83 | * AR_19668381_ChIP-Seq_PC3_Human | 1.15267402 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14068736 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11322961 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09183615 |
| 87 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.08381780 |
| 88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08179501 |
| 89 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08149889 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07771304 |
| 91 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07700285 |
| 92 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06640482 |
| 93 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.06011081 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05244381 |
| 95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05244381 |
| 96 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04983768 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04452159 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.04402698 |
| 99 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04067336 |
| 100 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03820015 |
| 101 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02331799 |
| 102 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02111309 |
| 103 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00758136 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99682615 |
| 105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98719944 |
| 106 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98397803 |
| 107 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98154059 |
| 108 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97084292 |
| 109 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97074034 |
| 110 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96281284 |
| 111 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.96201155 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95989351 |
| 113 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95821316 |
| 114 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95629598 |
| 115 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.95621247 |
| 116 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95571424 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95153988 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94888047 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 0.94617820 |
| 120 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94408913 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93854020 |
| 122 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93179908 |
| 123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92877918 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90774439 |
| 125 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.89816121 |
| 126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89346754 |
| 127 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88975149 |
| 128 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88975149 |
| 129 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88890447 |
| 130 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86934493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.85425898 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 5.15224239 |
| 3 | MP0003880_abnormal_central_pattern | 4.96762439 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.12380097 |
| 5 | MP0009046_muscle_twitch | 3.82739054 |
| 6 | MP0004270_analgesia | 3.59546471 |
| 7 | MP0009745_abnormal_behavioral_response | 3.50354009 |
| 8 | MP0002064_seizures | 3.39123797 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.27422895 |
| 10 | MP0004272_abnormal_basement_membrane | 3.12956784 |
| 11 | MP0005503_abnormal_tendon_morphology | 3.12491791 |
| 12 | MP0001968_abnormal_touch/_nociception | 3.11625909 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 3.10844940 |
| 14 | MP0003279_aneurysm | 3.04468895 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.96087544 |
| 16 | MP0001958_emphysema | 2.95688818 |
| 17 | MP0003950_abnormal_plasma_membrane | 2.95661274 |
| 18 | MP0002272_abnormal_nervous_system | 2.91989705 |
| 19 | MP0001486_abnormal_startle_reflex | 2.66967873 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.63946771 |
| 21 | MP0009384_cardiac_valve_regurgitation | 2.60428299 |
| 22 | MP0005623_abnormal_meninges_morphology | 2.56786401 |
| 23 | MP0002736_abnormal_nociception_after | 2.54202287 |
| 24 | MP0001501_abnormal_sleep_pattern | 2.47595012 |
| 25 | MP0002735_abnormal_chemical_nociception | 2.40334049 |
| 26 | MP0001440_abnormal_grooming_behavior | 2.36363674 |
| 27 | MP0005423_abnormal_somatic_nervous | 2.28228364 |
| 28 | MP0002067_abnormal_sensory_capabilities | 2.25872223 |
| 29 | MP0005670_abnormal_white_adipose | 2.21136557 |
| 30 | MP0005275_abnormal_skin_tensile | 2.16631884 |
| 31 | MP0005257_abnormal_intraocular_pressure | 2.13139326 |
| 32 | MP0006054_spinal_hemorrhage | 1.99660253 |
| 33 | MP0001542_abnormal_bone_strength | 1.99026364 |
| 34 | MP0001970_abnormal_pain_threshold | 1.89049822 |
| 35 | MP0003329_amyloid_beta_deposits | 1.88317292 |
| 36 | MP0003879_abnormal_hair_cell | 1.87935707 |
| 37 | MP0006276_abnormal_autonomic_nervous | 1.85585173 |
| 38 | MP0002184_abnormal_innervation | 1.85381320 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.84953797 |
| 40 | MP0008569_lethality_at_weaning | 1.83192489 |
| 41 | MP0000534_abnormal_ureter_morphology | 1.81768445 |
| 42 | MP0004130_abnormal_muscle_cell | 1.80944935 |
| 43 | MP0004924_abnormal_behavior | 1.79245474 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.79245474 |
| 45 | MP0000778_abnormal_nervous_system | 1.75581149 |
| 46 | MP0002557_abnormal_social/conspecific_i | 1.73324939 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.67959700 |
| 48 | MP0005595_abnormal_vascular_smooth | 1.67404825 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.64637495 |
| 50 | MP0001299_abnormal_eye_distance/ | 1.63221060 |
| 51 | MP0001984_abnormal_olfaction | 1.61100000 |
| 52 | MP0004142_abnormal_muscle_tone | 1.56129645 |
| 53 | MP0003091_abnormal_cell_migration | 1.53199328 |
| 54 | MP0002295_abnormal_pulmonary_circulatio | 1.52203118 |
| 55 | MP0010368_abnormal_lymphatic_system | 1.50889141 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.49842796 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.46836881 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.45740232 |
| 59 | MP0000955_abnormal_spinal_cord | 1.44418002 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.43633338 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 1.42928146 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.41451368 |
| 63 | MP0003283_abnormal_digestive_organ | 1.40239477 |
| 64 | MP0002882_abnormal_neuron_morphology | 1.37024144 |
| 65 | MP0004858_abnormal_nervous_system | 1.36279517 |
| 66 | MP0001348_abnormal_lacrimal_gland | 1.35586514 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.34731675 |
| 68 | MP0001529_abnormal_vocalization | 1.31532056 |
| 69 | MP0002822_catalepsy | 1.30652400 |
| 70 | MP0003942_abnormal_urinary_system | 1.30509326 |
| 71 | MP0003633_abnormal_nervous_system | 1.29513857 |
| 72 | MP0005508_abnormal_skeleton_morphology | 1.24702650 |
| 73 | MP0000751_myopathy | 1.23432184 |
| 74 | MP0002896_abnormal_bone_mineralization | 1.21917489 |
| 75 | MP0003787_abnormal_imprinting | 1.20357224 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.19221289 |
| 77 | MP0003631_nervous_system_phenotype | 1.15540147 |
| 78 | MP0000538_abnormal_urinary_bladder | 1.13917182 |
| 79 | MP0000767_abnormal_smooth_muscle | 1.13108203 |
| 80 | MP0001188_hyperpigmentation | 1.11951189 |
| 81 | MP0009250_abnormal_appendicular_skeleto | 1.11468196 |
| 82 | MP0001502_abnormal_circadian_rhythm | 1.11285531 |
| 83 | MP0008872_abnormal_physiological_respon | 1.11144363 |
| 84 | MP0004742_abnormal_vestibular_system | 1.10003535 |
| 85 | MP0002909_abnormal_adrenal_gland | 1.09394048 |
| 86 | MP0003868_abnormal_feces_composition | 1.06706343 |
| 87 | MP0002971_abnormal_brown_adipose | 1.06378076 |
| 88 | MP0000749_muscle_degeneration | 1.05841488 |
| 89 | MP0000230_abnormal_systemic_arterial | 1.05815966 |
| 90 | MP0002152_abnormal_brain_morphology | 1.04589157 |
| 91 | MP0002229_neurodegeneration | 1.04442857 |
| 92 | MP0004885_abnormal_endolymph | 1.03039969 |
| 93 | MP0004145_abnormal_muscle_electrophysio | 1.02154256 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 1.01501023 |
| 95 | MP0008874_decreased_physiological_sensi | 1.00124510 |
| 96 | MP0009053_abnormal_anal_canal | 0.99999802 |
| 97 | MP0003122_maternal_imprinting | 0.98423247 |
| 98 | MP0003690_abnormal_glial_cell | 0.98344709 |
| 99 | MP0004036_abnormal_muscle_relaxation | 0.98044457 |
| 100 | MP0005023_abnormal_wound_healing | 0.97844079 |
| 101 | MP0005620_abnormal_muscle_contractility | 0.97770753 |
| 102 | MP0003941_abnormal_skin_development | 0.97173565 |
| 103 | MP0001905_abnormal_dopamine_level | 0.96603906 |
| 104 | MP0001963_abnormal_hearing_physiology | 0.95320818 |
| 105 | MP0003959_abnormal_lean_body | 0.94626531 |
| 106 | MP0004084_abnormal_cardiac_muscle | 0.94191456 |
| 107 | MP0005535_abnormal_body_temperature | 0.93374687 |
| 108 | MP0000604_amyloidosis | 0.92800369 |
| 109 | MP0000428_abnormal_craniofacial_morphol | 0.91193006 |
| 110 | MP0003632_abnormal_nervous_system | 0.90945433 |
| 111 | MP0002069_abnormal_eating/drinking_beha | 0.90860475 |
| 112 | MP0001177_atelectasis | 0.88987012 |
| 113 | MP0004085_abnormal_heartbeat | 0.88372039 |
| 114 | MP0008004_abnormal_stomach_pH | 0.87880694 |
| 115 | MP0006138_congestive_heart_failure | 0.87746440 |
| 116 | MP0003045_fibrosis | 0.87488102 |
| 117 | MP0000013_abnormal_adipose_tissue | 0.85650459 |
| 118 | MP0010386_abnormal_urinary_bladder | 0.85417618 |
| 119 | MP0005187_abnormal_penis_morphology | 0.84794908 |
| 120 | MP0004215_abnormal_myocardial_fiber | 0.84774689 |
| 121 | MP0003252_abnormal_bile_duct | 0.83446755 |
| 122 | MP0002108_abnormal_muscle_morphology | 0.83311068 |
| 123 | MP0002752_abnormal_somatic_nervous | 0.81894274 |
| 124 | MP0003646_muscle_fatigue | 0.81520692 |
| 125 | MP0004484_altered_response_of | 0.80522347 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.80405737 |
| 127 | MP0004043_abnormal_pH_regulation | 0.80084017 |
| 128 | MP0004134_abnormal_chest_morphology | 0.78799031 |
| 129 | MP0000920_abnormal_myelination | 0.76541484 |
| 130 | MP0000631_abnormal_neuroendocrine_gland | 0.75557679 |
| 131 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75104072 |
| 132 | MP0003385_abnormal_body_wall | 0.72992977 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.72653907 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.72013114 |
| 135 | MP0002090_abnormal_vision | 0.71369487 |
| 136 | MP0003634_abnormal_glial_cell | 0.68275125 |
| 137 | MP0003075_altered_response_to | 0.65396604 |
| 138 | MP0005394_taste/olfaction_phenotype | 0.64858089 |
| 139 | MP0005499_abnormal_olfactory_system | 0.64858089 |
| 140 | MP0001664_abnormal_digestion | 0.64450871 |
| 141 | MP0000733_abnormal_muscle_development | 0.64410915 |
| 142 | MP0003137_abnormal_impulse_conducting | 0.63209586 |
| 143 | MP0000427_abnormal_hair_cycle | 0.61766372 |
| 144 | MP0000163_abnormal_cartilage_morphology | 0.61249850 |
| 145 | MP0000759_abnormal_skeletal_muscle | 0.60408762 |
| 146 | MP0005360_urolithiasis | 0.60005257 |
| 147 | MP0002115_abnormal_skeleton_extremities | 0.59802550 |
| 148 | MP0001485_abnormal_pinna_reflex | 0.59159208 |
| 149 | MP0001943_abnormal_respiration | 0.55206518 |
| 150 | MP0005085_abnormal_gallbladder_physiolo | 0.54628872 |
| 151 | MP0000026_abnormal_inner_ear | 0.54397650 |
| 152 | MP0010770_preweaning_lethality | 0.53976068 |
| 153 | MP0002082_postnatal_lethality | 0.53976068 |
| 154 | MP0010329_abnormal_lipoprotein_level | 0.53940477 |
| 155 | MP0004233_abnormal_muscle_weight | 0.53738788 |
| 156 | MP0010769_abnormal_survival | 0.53294073 |
| 157 | MP0006072_abnormal_retinal_apoptosis | 0.53222185 |
| 158 | MP0002638_abnormal_pupillary_reflex | 0.51449390 |
| 159 | MP0005253_abnormal_eye_physiology | 0.50341121 |
| 160 | MP0010768_mortality/aging | 0.49951368 |
| 161 | MP0003956_abnormal_body_size | 0.48637113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.29931254 |
| 2 | Premature rupture of membranes (HP:0001788) | 6.48031999 |
| 3 | Focal seizures (HP:0007359) | 5.87591208 |
| 4 | Atonic seizures (HP:0010819) | 5.80396671 |
| 5 | Myokymia (HP:0002411) | 5.79810164 |
| 6 | Aortic aneurysm (HP:0004942) | 5.75770630 |
| 7 | Protrusio acetabuli (HP:0003179) | 5.64295744 |
| 8 | Epileptic encephalopathy (HP:0200134) | 5.54821567 |
| 9 | Febrile seizures (HP:0002373) | 5.11385595 |
| 10 | Aortic dissection (HP:0002647) | 5.03838340 |
| 11 | Hyperventilation (HP:0002883) | 4.97109427 |
| 12 | Visual hallucinations (HP:0002367) | 4.92442656 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 4.91265670 |
| 14 | Absence seizures (HP:0002121) | 4.80597589 |
| 15 | Ankle contracture (HP:0006466) | 4.49881424 |
| 16 | Follicular hyperkeratosis (HP:0007502) | 4.35235117 |
| 17 | Dialeptic seizures (HP:0011146) | 4.25560523 |
| 18 | Generalized tonic-clonic seizures (HP:0002069) | 4.19073622 |
| 19 | Gaze-evoked nystagmus (HP:0000640) | 4.02867231 |
| 20 | Action tremor (HP:0002345) | 4.00249488 |
| 21 | Broad-based gait (HP:0002136) | 3.97569398 |
| 22 | Vascular tortuosity (HP:0004948) | 3.91485140 |
| 23 | Type 1 muscle fiber predominance (HP:0003803) | 3.72929267 |
| 24 | Dysdiadochokinesis (HP:0002075) | 3.72594379 |
| 25 | Spinal rigidity (HP:0003306) | 3.70999416 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.68113239 |
| 27 | Neonatal short-limb short stature (HP:0008921) | 3.67894509 |
| 28 | Soft skin (HP:0000977) | 3.59570515 |
| 29 | Scanning speech (HP:0002168) | 3.50056409 |
| 30 | Bladder diverticulum (HP:0000015) | 3.38537895 |
| 31 | Dysmetria (HP:0001310) | 3.35834337 |
| 32 | Arterial tortuosity (HP:0005116) | 3.35554694 |
| 33 | Abnormality of dentin (HP:0010299) | 3.34777998 |
| 34 | Slender build (HP:0001533) | 3.33603087 |
| 35 | Hypoventilation (HP:0002791) | 3.30425946 |
| 36 | Poor eye contact (HP:0000817) | 3.20351489 |
| 37 | Amblyopia (HP:0000646) | 3.13454893 |
| 38 | Broad metatarsal (HP:0001783) | 3.10278872 |
| 39 | Shallow orbits (HP:0000586) | 3.07856763 |
| 40 | Excessive salivation (HP:0003781) | 3.04598170 |
| 41 | Drooling (HP:0002307) | 3.04598170 |
| 42 | Wormian bones (HP:0002645) | 3.03919908 |
| 43 | Atrophic scars (HP:0001075) | 3.02724580 |
| 44 | Abnormal social behavior (HP:0012433) | 3.01425460 |
| 45 | Impaired social interactions (HP:0000735) | 3.01425460 |
| 46 | Truncal ataxia (HP:0002078) | 2.96775275 |
| 47 | Genetic anticipation (HP:0003743) | 2.96470463 |
| 48 | Status epilepticus (HP:0002133) | 2.93358031 |
| 49 | Epileptiform EEG discharges (HP:0011182) | 2.89467196 |
| 50 | Abnormal eating behavior (HP:0100738) | 2.89308938 |
| 51 | Impaired smooth pursuit (HP:0007772) | 2.88526251 |
| 52 | Dysmetric saccades (HP:0000641) | 2.82010113 |
| 53 | Abnormality of the lower motor neuron (HP:0002366) | 2.80199830 |
| 54 | Wide anterior fontanel (HP:0000260) | 2.77141420 |
| 55 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.71363458 |
| 56 | Postural instability (HP:0002172) | 2.70418572 |
| 57 | Genu recurvatum (HP:0002816) | 2.68387577 |
| 58 | Anxiety (HP:0000739) | 2.65401409 |
| 59 | EEG with generalized epileptiform discharges (HP:0011198) | 2.64002152 |
| 60 | Depression (HP:0000716) | 2.58697606 |
| 61 | Impaired vibratory sensation (HP:0002495) | 2.57668487 |
| 62 | Abnormality of binocular vision (HP:0011514) | 2.57278798 |
| 63 | Diplopia (HP:0000651) | 2.57278798 |
| 64 | Supranuclear gaze palsy (HP:0000605) | 2.55770497 |
| 65 | Absent speech (HP:0001344) | 2.55296816 |
| 66 | Bowel diverticulosis (HP:0005222) | 2.52220723 |
| 67 | Increased mean platelet volume (HP:0011877) | 2.52090151 |
| 68 | Hemiplegia (HP:0002301) | 2.51900575 |
| 69 | Abnormality of the corticospinal tract (HP:0002492) | 2.50474319 |
| 70 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.49205312 |
| 71 | Protruding tongue (HP:0010808) | 2.48705408 |
| 72 | Overgrowth (HP:0001548) | 2.48605838 |
| 73 | Hemiparesis (HP:0001269) | 2.47458085 |
| 74 | Increased variability in muscle fiber diameter (HP:0003557) | 2.47349290 |
| 75 | Progressive inability to walk (HP:0002505) | 2.47270676 |
| 76 | Spastic gait (HP:0002064) | 2.47039877 |
| 77 | Intention tremor (HP:0002080) | 2.46345061 |
| 78 | Hypsarrhythmia (HP:0002521) | 2.46287404 |
| 79 | Termporal pattern (HP:0011008) | 2.45665352 |
| 80 | Insidious onset (HP:0003587) | 2.45665352 |
| 81 | Generalized myoclonic seizures (HP:0002123) | 2.44469709 |
| 82 | Inability to walk (HP:0002540) | 2.42875150 |
| 83 | Fragile skin (HP:0001030) | 2.42452614 |
| 84 | Polyphagia (HP:0002591) | 2.41491532 |
| 85 | Abnormality of saccadic eye movements (HP:0000570) | 2.36857127 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 2.31130996 |
| 87 | Mitral valve prolapse (HP:0001634) | 2.29161358 |
| 88 | Blue irides (HP:0000635) | 2.28691879 |
| 89 | Peritonitis (HP:0002586) | 2.28497548 |
| 90 | Knee flexion contracture (HP:0006380) | 2.27178081 |
| 91 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26974467 |
| 92 | Spondylolisthesis (HP:0003302) | 2.26260717 |
| 93 | Aortic regurgitation (HP:0001659) | 2.24422465 |
| 94 | Bradykinesia (HP:0002067) | 2.23856249 |
| 95 | Ankle clonus (HP:0011448) | 2.23153406 |
| 96 | Elbow flexion contracture (HP:0002987) | 2.22609414 |
| 97 | Mild short stature (HP:0003502) | 2.22550171 |
| 98 | Mutism (HP:0002300) | 2.22239795 |
| 99 | Fetal akinesia sequence (HP:0001989) | 2.22183383 |
| 100 | Cervical subluxation (HP:0003308) | 2.21955276 |
| 101 | Urinary urgency (HP:0000012) | 2.21198923 |
| 102 | Dilatation of the ascending aorta (HP:0005111) | 2.20306669 |
| 103 | Long toe (HP:0010511) | 2.20003239 |
| 104 | Blue sclerae (HP:0000592) | 2.19417946 |
| 105 | Neurofibrillary tangles (HP:0002185) | 2.18549227 |
| 106 | Coronal craniosynostosis (HP:0004440) | 2.16801951 |
| 107 | Aneurysm (HP:0002617) | 2.14250750 |
| 108 | Hyperextensible skin (HP:0000974) | 2.14248811 |
| 109 | Gait ataxia (HP:0002066) | 2.13705357 |
| 110 | Gait imbalance (HP:0002141) | 2.13429100 |
| 111 | Keratoconus (HP:0000563) | 2.10399943 |
| 112 | Increased corneal curvature (HP:0100692) | 2.10399943 |
| 113 | Pheochromocytoma (HP:0002666) | 2.09118348 |
| 114 | Bradycardia (HP:0001662) | 2.08983084 |
| 115 | Stereotypic behavior (HP:0000733) | 2.08513485 |
| 116 | Morphological abnormality of the middle ear (HP:0008609) | 2.07061307 |
| 117 | Fair hair (HP:0002286) | 2.06598917 |
| 118 | Focal dystonia (HP:0004373) | 2.04637793 |
| 119 | Broad ribs (HP:0000885) | 2.03961552 |
| 120 | Abnormal platelet volume (HP:0011876) | 2.02496739 |
| 121 | Esotropia (HP:0000565) | 2.02345237 |
| 122 | Torticollis (HP:0000473) | 2.02340827 |
| 123 | Cardiovascular calcification (HP:0011915) | 2.01036355 |
| 124 | Abnormality of salivation (HP:0100755) | 2.00340001 |
| 125 | Complete atrioventricular canal defect (HP:0001674) | 2.00182862 |
| 126 | Distal upper limb amyotrophy (HP:0007149) | 1.97559722 |
| 127 | Upper limb amyotrophy (HP:0009129) | 1.97559722 |
| 128 | Generalized hypopigmentation of hair (HP:0011358) | 1.97556092 |
| 129 | Lower limb amyotrophy (HP:0007210) | 1.96202166 |
| 130 | Joint laxity (HP:0001388) | 1.95247918 |
| 131 | Mitral stenosis (HP:0001718) | 1.95073130 |
| 132 | Neuroendocrine neoplasm (HP:0100634) | 1.93452384 |
| 133 | Abnormality of proline metabolism (HP:0010907) | 1.92011985 |
| 134 | Hydroxyprolinuria (HP:0003080) | 1.92011985 |
| 135 | Agitation (HP:0000713) | 1.91146363 |
| 136 | Anterior segment dysgenesis (HP:0007700) | 1.90768368 |
| 137 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.90345165 |
| 138 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.90345165 |
| 139 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.90056559 |
| 140 | Hydroureter (HP:0000072) | 1.89401228 |
| 141 | Biconcave vertebral bodies (HP:0004586) | 1.88483478 |
| 142 | Aortic valve stenosis (HP:0001650) | 1.87689530 |
| 143 | Mitral regurgitation (HP:0001653) | 1.87142156 |
| 144 | Incomplete penetrance (HP:0003829) | 1.86812933 |
| 145 | Obstructive sleep apnea (HP:0002870) | 1.86752989 |
| 146 | Specific learning disability (HP:0001328) | 1.86285580 |
| 147 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.85749272 |
| 148 | Psychosis (HP:0000709) | 1.85572504 |
| 149 | Neuronal loss in central nervous system (HP:0002529) | 1.84928418 |
| 150 | Lower limb muscle weakness (HP:0007340) | 1.84356014 |
| 151 | Abnormal delivery (HP:0001787) | 1.83440537 |
| 152 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.83432829 |
| 153 | Absent/shortened dynein arms (HP:0200106) | 1.83432829 |
| 154 | Congenital primary aphakia (HP:0007707) | 1.82886525 |
| 155 | Abnormal ciliary motility (HP:0012262) | 1.82419903 |
| 156 | Hypoplasia of the iris (HP:0007676) | 1.80401958 |
| 157 | Abnormal hair whorl (HP:0010721) | 1.80190357 |
| 158 | Hyperthyroidism (HP:0000836) | 1.77202721 |
| 159 | Medial flaring of the eyebrow (HP:0010747) | 1.76141344 |
| 160 | Facial shape deformation (HP:0011334) | 1.74723387 |
| 161 | Potter facies (HP:0002009) | 1.74723387 |
| 162 | Limb ataxia (HP:0002070) | 1.73860200 |
| 163 | Narrow nasal bridge (HP:0000446) | 1.72954856 |
| 164 | Craniofacial dystonia (HP:0012179) | 1.71314685 |
| 165 | Ventricular fibrillation (HP:0001663) | 1.70390842 |
| 166 | Syringomyelia (HP:0003396) | 1.69983338 |
| 167 | Spinal cord lesions (HP:0100561) | 1.69983338 |
| 168 | Poor suck (HP:0002033) | 1.68671427 |
| 169 | Ulnar bowing (HP:0003031) | 1.66718844 |
| 170 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.66417391 |
| 171 | Prominent supraorbital ridges (HP:0000336) | 1.65625131 |
| 172 | Horizontal nystagmus (HP:0000666) | 1.65602408 |
| 173 | Ileus (HP:0002595) | 1.64963507 |
| 174 | Wrist flexion contracture (HP:0001239) | 1.64445665 |
| 175 | Buphthalmos (HP:0000557) | 1.64236556 |
| 176 | Abnormality of the anterior chamber (HP:0000593) | 1.64210849 |
| 177 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.63374728 |
| 178 | Osteolytic defects of the hand bones (HP:0009699) | 1.63374728 |
| 179 | Bronchomalacia (HP:0002780) | 1.63330861 |
| 180 | Limb-girdle muscle weakness (HP:0003325) | 1.62899443 |
| 181 | Atrioventricular canal defect (HP:0006695) | 1.62815488 |
| 182 | Stridor (HP:0010307) | 1.62747475 |
| 183 | Round face (HP:0000311) | 1.62493679 |
| 184 | Ectopia lentis (HP:0001083) | 1.60008573 |
| 185 | Achilles tendon contracture (HP:0001771) | 1.59355880 |
| 186 | Type II lissencephaly (HP:0007260) | 1.59207963 |
| 187 | Abnormality of the acetabulum (HP:0003170) | 1.57577110 |
| 188 | Distal lower limb amyotrophy (HP:0008944) | 1.57240088 |
| 189 | Mesomelia (HP:0003027) | 1.56959990 |
| 190 | Deviation of the hallux (HP:0010051) | 1.56367061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYLK | 5.24542658 |
| 2 | EPHA4 | 4.22005724 |
| 3 | CASK | 4.09300497 |
| 4 | NTRK3 | 4.04144068 |
| 5 | MAP3K4 | 3.46801735 |
| 6 | MAP2K7 | 3.13102488 |
| 7 | MAP3K12 | 3.07475882 |
| 8 | DAPK2 | 2.88088617 |
| 9 | MAP3K9 | 2.62471071 |
| 10 | CDK19 | 2.53022519 |
| 11 | FRK | 2.51862197 |
| 12 | MAP2K4 | 2.46317392 |
| 13 | MARK1 | 2.46042915 |
| 14 | DDR2 | 2.34553697 |
| 15 | PDGFRA | 2.28066382 |
| 16 | PAK2 | 2.23982299 |
| 17 | MINK1 | 2.20611575 |
| 18 | PTK2 | 2.19211159 |
| 19 | NTRK2 | 2.07925001 |
| 20 | RIPK4 | 2.01169372 |
| 21 | DAPK1 | 1.94480630 |
| 22 | PAK6 | 1.78946533 |
| 23 | NEK9 | 1.70016513 |
| 24 | PLK2 | 1.63450149 |
| 25 | PIK3CG | 1.63325928 |
| 26 | TTN | 1.62300751 |
| 27 | ADRBK2 | 1.61584561 |
| 28 | LIMK1 | 1.60894247 |
| 29 | OXSR1 | 1.54288268 |
| 30 | CAMKK2 | 1.47878240 |
| 31 | SIK2 | 1.47471148 |
| 32 | GRK5 | 1.45587136 |
| 33 | MAPK13 | 1.43283775 |
| 34 | CAMKK1 | 1.41890891 |
| 35 | CDK5 | 1.39092681 |
| 36 | PRKCG | 1.37262894 |
| 37 | LMTK2 | 1.36165782 |
| 38 | NTRK1 | 1.35496363 |
| 39 | TNIK | 1.34236407 |
| 40 | PNCK | 1.33178864 |
| 41 | GRK1 | 1.33007598 |
| 42 | PRKD2 | 1.31450811 |
| 43 | FLT3 | 1.29729548 |
| 44 | TESK1 | 1.26486363 |
| 45 | PRKG2 | 1.23355278 |
| 46 | LATS1 | 1.22022772 |
| 47 | ROCK1 | 1.16725440 |
| 48 | CAMK2A | 1.15653224 |
| 49 | PRPF4B | 1.15357397 |
| 50 | SIK1 | 1.15193977 |
| 51 | KSR1 | 1.13908096 |
| 52 | EPHB2 | 1.12708455 |
| 53 | MET | 1.12026447 |
| 54 | PIM2 | 1.11556825 |
| 55 | KSR2 | 1.10326878 |
| 56 | STK38 | 1.09209997 |
| 57 | AKT3 | 1.08229306 |
| 58 | FES | 1.05499905 |
| 59 | CAMK2B | 1.05487598 |
| 60 | TRPM7 | 1.04895875 |
| 61 | SGK494 | 1.01727720 |
| 62 | SGK223 | 1.01727720 |
| 63 | CAMK1 | 0.99438610 |
| 64 | SGK2 | 0.97527862 |
| 65 | BMPR2 | 0.96678329 |
| 66 | CCNB1 | 0.96557398 |
| 67 | RIPK1 | 0.95689793 |
| 68 | PTK2B | 0.95488024 |
| 69 | MELK | 0.95156808 |
| 70 | PRKD3 | 0.92544784 |
| 71 | MAP2K1 | 0.88834114 |
| 72 | UHMK1 | 0.86334786 |
| 73 | PDGFRB | 0.84073454 |
| 74 | ARAF | 0.81510420 |
| 75 | STK11 | 0.78451716 |
| 76 | DMPK | 0.77972782 |
| 77 | CDK18 | 0.75625569 |
| 78 | ERBB4 | 0.74969048 |
| 79 | MAP3K13 | 0.74188889 |
| 80 | CDK15 | 0.73434869 |
| 81 | WNK4 | 0.71555859 |
| 82 | RPS6KA2 | 0.71226462 |
| 83 | BRAF | 0.70579712 |
| 84 | ACVR1B | 0.70292109 |
| 85 | PRKCH | 0.69208149 |
| 86 | CDK14 | 0.68669100 |
| 87 | ABL2 | 0.68646369 |
| 88 | STK39 | 0.68161296 |
| 89 | TRIB3 | 0.68099682 |
| 90 | PRKCE | 0.67915008 |
| 91 | SGK3 | 0.67836043 |
| 92 | CAMK4 | 0.67817921 |
| 93 | MOS | 0.67769683 |
| 94 | IRAK1 | 0.67568070 |
| 95 | SGK1 | 0.66583251 |
| 96 | CAMK2G | 0.65051590 |
| 97 | DYRK1B | 0.64947288 |
| 98 | PAK1 | 0.64904110 |
| 99 | DYRK1A | 0.64300477 |
| 100 | PHKG2 | 0.64049893 |
| 101 | PHKG1 | 0.64049893 |
| 102 | WNK3 | 0.63339036 |
| 103 | FGR | 0.62535848 |
| 104 | CAMK2D | 0.62396701 |
| 105 | MARK2 | 0.62083652 |
| 106 | NME1 | 0.61877028 |
| 107 | CDK11A | 0.61507233 |
| 108 | GSK3A | 0.60439115 |
| 109 | CAMK1G | 0.58874601 |
| 110 | PDK1 | 0.58243507 |
| 111 | PDK4 | 0.55802679 |
| 112 | PDK3 | 0.55802679 |
| 113 | PRKD1 | 0.55358895 |
| 114 | DAPK3 | 0.54598585 |
| 115 | MAP3K2 | 0.54561340 |
| 116 | MAP3K6 | 0.54322097 |
| 117 | MAPK12 | 0.53456322 |
| 118 | ROCK2 | 0.53310300 |
| 119 | WNK1 | 0.53247720 |
| 120 | FER | 0.53067260 |
| 121 | TYRO3 | 0.52496640 |
| 122 | PAK3 | 0.51533389 |
| 123 | PDPK1 | 0.50806885 |
| 124 | STK38L | 0.49885148 |
| 125 | ILK | 0.49254330 |
| 126 | PINK1 | 0.49253507 |
| 127 | LATS2 | 0.49138700 |
| 128 | CSNK1G2 | 0.48753824 |
| 129 | CDC42BPA | 0.47789228 |
| 130 | MTOR | 0.47365642 |
| 131 | TNK2 | 0.47154154 |
| 132 | RPS6KA3 | 0.47082192 |
| 133 | PRKCZ | 0.46494009 |
| 134 | SIK3 | 0.46055481 |
| 135 | PRKAA1 | 0.44775616 |
| 136 | BCR | 0.44751083 |
| 137 | INSRR | 0.44474972 |
| 138 | RET | 0.44395326 |
| 139 | FGFR2 | 0.43455027 |
| 140 | NEK6 | 0.42756213 |
| 141 | PIK3CA | 0.42597004 |
| 142 | FYN | 0.40363853 |
| 143 | PRKACA | 0.39772590 |
| 144 | BMX | 0.39515186 |
| 145 | TIE1 | 0.39163736 |
| 146 | ADRBK1 | 0.37219321 |
| 147 | PRKCB | 0.36522525 |
| 148 | GRK7 | 0.36278189 |
| 149 | MAPKAPK3 | 0.36232039 |
| 150 | MUSK | 0.36004742 |
| 151 | PRKG1 | 0.35966436 |
| 152 | PRKCA | 0.35670124 |
| 153 | CDK8 | 0.29963318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.41352625 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.31023402 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.90298056 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.75092234 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.72562287 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.66946748 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.60705087 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.59230436 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.46725289 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.35151783 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.27706066 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.15533093 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.03674949 |
| 14 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.99019313 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 1.97276801 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.90304571 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.88646140 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.88165757 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.84049389 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73739383 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.70122425 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69303606 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65297744 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63171046 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.57084617 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54466455 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51080479 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50665626 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.46524615 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.45676138 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45446996 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.27622686 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.26905470 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.25576691 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.25149219 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.22998760 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.20390975 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19773453 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19098042 |
| 40 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.18515566 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18436752 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.17255211 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16050788 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.13327838 |
| 45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11098741 |
| 46 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.06834078 |
| 47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.06671244 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06190446 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06005423 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 1.04564484 |
| 51 | Melanoma_Homo sapiens_hsa05218 | 1.03056704 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 1.02572034 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01552068 |
| 54 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.01152668 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.96700222 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96521595 |
| 57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95170165 |
| 58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91211763 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.90929020 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89557215 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.88951848 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88946945 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88509186 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.87488973 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.83791628 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82933131 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80012799 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.79044081 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78970184 |
| 70 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78546382 |
| 71 | Melanogenesis_Homo sapiens_hsa04916 | 0.76983809 |
| 72 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.76284600 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.76193948 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75912186 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74861423 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.73842402 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71286081 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70910202 |
| 79 | Glioma_Homo sapiens_hsa05214 | 0.70390472 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70278465 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68110125 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.67731279 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66543688 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.65405861 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64643019 |
| 86 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.63420672 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63162697 |
| 88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.61679161 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.58703718 |
| 90 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58489507 |
| 91 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55938879 |
| 92 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55927719 |
| 93 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54547210 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53867718 |
| 95 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53697983 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53093699 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.52362155 |
| 98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.52058025 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50597231 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50085112 |
| 101 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50077840 |
| 102 | Parkinsons disease_Homo sapiens_hsa05012 | 0.47694357 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47245738 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44288636 |
| 105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44206388 |
| 106 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.43961305 |
| 107 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42301584 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42204220 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41606887 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41199011 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39170762 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38700865 |
| 113 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38468243 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38462173 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38150374 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38047817 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37596274 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36735628 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35453019 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35335685 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35002618 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33481431 |
| 123 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32226993 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31829732 |
| 125 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30666964 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30612586 |
| 127 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.30549002 |
| 128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28640694 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.28393626 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26735053 |
| 131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24408875 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23812613 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.23121242 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22432431 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22061470 |
| 136 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.21463950 |
| 137 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20203272 |

